Genomic landscape of neutrophilic leukemias of ambiguous diagnosis.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
12 09 2019
Historique:
received: 14 03 2019
accepted: 27 06 2019
pubmed: 2 8 2019
medline: 24 1 2020
entrez: 2 8 2019
Statut: ppublish

Résumé

Chronic neutrophilic leukemia (CNL), atypical chronic myeloid leukemia (aCML), and myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN-U) are a group of rare and heterogeneous myeloid disorders. There is strong morphologic resemblance among these distinct diagnostic entities as well as a lack of specific molecular markers and limited understanding of disease pathogenesis, which has made diagnosis challenging in certain cases. The treatment has remained empirical, resulting in dismal outcomes. We, therefore, performed whole-exome and RNA sequencing of these rare hematologic malignancies and present the most complete survey of the genomic landscape of these diseases to date. We observed a diversity of combinatorial mutational patterns that generally do not cluster within any one diagnosis. Gene expression analysis reveals enrichment, but not cosegregation, of clinical and genetic disease features with transcriptional clusters. In conclusion, these groups of diseases represent a continuum of related diseases rather than discrete diagnostic entities.

Identifiants

pubmed: 31366621
pii: S0006-4971(20)30007-0
doi: 10.1182/blood.2019000611
pmc: PMC6742922
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

867-879

Subventions

Organisme : NCI NIH HHS
ID : K99 CA190605
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA224019
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA183974
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA066996
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA217862
Pays : United States
Organisme : NCI NIH HHS
ID : R00 CA190605
Pays : United States
Organisme : NCI NIH HHS
ID : K99 CA237630
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 by The American Society of Hematology.

Références

N Engl J Med. 2013 May 9;368(19):1781-90
pubmed: 23656643
Blood. 2010 Jan 7;115(1):38-46
pubmed: 19861679
Leukemia. 2017 Dec;31(12):2815-2823
pubmed: 28555081
Blood. 2015 Mar 19;125(12):1857-65
pubmed: 25624319
Blood. 2013 Nov 21;122(22):3628-31
pubmed: 24081659
J Clin Oncol. 2017 Mar 20;35(9):947-954
pubmed: 28297629
Nat Rev Cancer. 2017 Jun 23;17(7):425-440
pubmed: 28642604
Haematologica. 2015 Sep;100(9):1117-30
pubmed: 26341525
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Leuk Res Rep. 2014 Aug 01;3(2):67-9
pubmed: 25180155
Blood. 2013 Sep 5;122(10):1707-11
pubmed: 23896413
Nat Genet. 2011 Dec 11;44(1):53-7
pubmed: 22158538
Leukemia. 2018 Sep;32(9):2046-2049
pubmed: 29899367
Cold Spring Harb Mol Case Stud. 2018 Dec 17;4(6):
pubmed: 30559310
Sci Rep. 2014 Aug 27;4:6207
pubmed: 25158761
Eur J Haematol. 2015 Jul;95(1):3-15
pubmed: 25645650
Nat Genet. 2015 Nov;47(11):1326-1333
pubmed: 26457647
Blood. 2017 Feb 9;129(6):715-722
pubmed: 28028025
N Engl J Med. 2013 May 30;368(22):2059-74
pubmed: 23634996
Leukemia. 2013 Oct;27(10):2072-5
pubmed: 23648668
Nature. 2018 Oct;562(7728):526-531
pubmed: 30333627
Eur J Haematol. 2018 Sep;101(3):260-271
pubmed: 29742289
Blood. 2016 Aug 4;128(5):686-98
pubmed: 27288520
Nat Genet. 2013 Aug;45(8):942-6
pubmed: 23832012
Blood. 2017 Mar 9;129(10):1260-1269
pubmed: 27940478
J Clin Oncol. 2010 Aug 20;28(24):3858-65
pubmed: 20644105
Leukemia. 2014 Feb;28(2):241-7
pubmed: 24220272
Hematol Oncol Clin North Am. 2017 Aug;31(4):ix-x
pubmed: 28673398
Leukemia. 2016 Apr;30(4):906-13
pubmed: 26648538
Leukemia. 2008 Jul;22(7):1335-42
pubmed: 18548091
Ann Hematol. 2016 Jun;95(7):1197-200
pubmed: 27068405
Haematologica. 2014 Dec;99(12):e244-6
pubmed: 25239264
Blood. 2018 Feb 15;131(7):782-786
pubmed: 29288169
Blood. 2014 Apr 24;123(17):2645-51
pubmed: 24627528
Blood. 2012 Oct 11;120(15):3080-8
pubmed: 22919025
Blood. 2014 Apr 3;123(14):2220-8
pubmed: 24478400
Nat Genet. 2013 Jan;45(1):18-24
pubmed: 23222956
Bioinformatics. 2007 Mar 15;23(6):657-63
pubmed: 17234643
Nat Genet. 2015 Nov;47(11):1334-40
pubmed: 26457648

Auteurs

Haijiao Zhang (H)

Department of Cell, Developmental and Cancer Biology.
Division of Hematology and Medical Oncology, and.

Beth Wilmot (B)

Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR.

Daniel Bottomly (D)

Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR.

Kim-Hien T Dao (KT)

Division of Hematology and Medical Oncology, and.

Emily Stevens (E)

Fred Hutchinson Cancer Research Institute, Washington University School of Medicine, Seattle, WA.

Christopher A Eide (CA)

Division of Hematology and Medical Oncology, and.
Howard Hughes Medical Institute, Chevy Chase, MD.

Vishesh Khanna (V)

Division of Hematology and Medical Oncology, and.
Howard Hughes Medical Institute, Chevy Chase, MD.

Angela Rofelty (A)

Department of Cell, Developmental and Cancer Biology.
Division of Hematology and Medical Oncology, and.

Samantha Savage (S)

Department of Cell, Developmental and Cancer Biology.
Division of Hematology and Medical Oncology, and.

Anna Reister Schultz (A)

Department of Cell, Developmental and Cancer Biology.
Division of Hematology and Medical Oncology, and.

Nicola Long (N)

Department of Cell, Developmental and Cancer Biology.
Division of Hematology and Medical Oncology, and.

Libbey White (L)

Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR.

Amy Carlos (A)

Integrated Genomics Laboratories, Oregon Health & Science University, Portland, OR.

Rachel Henson (R)

Integrated Genomics Laboratories, Oregon Health & Science University, Portland, OR.

Chenwei Lin (C)

Integrated Genomics Laboratories, Oregon Health & Science University, Portland, OR.

Robert Searles (R)

Integrated Genomics Laboratories, Oregon Health & Science University, Portland, OR.

Robert H Collins (RH)

Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.

Daniel J DeAngelo (DJ)

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

Michael W Deininger (MW)

Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.

Tamara Dunn (T)

Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.

Than Hein (T)

Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.

Marlise R Luskin (MR)

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

Bruno C Medeiros (BC)

Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.

Stephen T Oh (ST)

Hematology Division, Department of Medicine, Washington University School of Medicine, Washington University in St. Louis, St. Louis, MO; and.

Daniel A Pollyea (DA)

Division of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado School of Medicine, Aurora, CO.

David P Steensma (DP)

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

Richard M Stone (RM)

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.

Brian J Druker (BJ)

Division of Hematology and Medical Oncology, and.
Howard Hughes Medical Institute, Chevy Chase, MD.

Shannon K McWeeney (SK)

Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR.

Julia E Maxson (JE)

Division of Hematology and Medical Oncology, and.

Jason R Gotlib (JR)

Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA.

Jeffrey W Tyner (JW)

Department of Cell, Developmental and Cancer Biology.
Division of Hematology and Medical Oncology, and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH